pirenzepine has been researched along with Cardiovascular Diseases in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Zwieten, PA | 1 |
| Doods, HN | 1 |
| Bouchard, RH | 1 |
| Demers, MF | 1 |
| Simoneau, I | 1 |
| Alméras, N | 1 |
| Villeneuve, J | 1 |
| Mottard, JP | 1 |
| Cadrin, C | 1 |
| Lemieux, I | 1 |
| Després, JP | 1 |
1 review available for pirenzepine and Cardiovascular Diseases
| Article | Year |
|---|---|
Muscarinic receptors and drugs in cardiovascular medicine.
Topics: Bradycardia; Cardiovascular Diseases; Cholinergic Agents; Endothelium, Vascular; Humans; Muscarinic | 1995 |
1 other study available for pirenzepine and Cardiovascular Diseases
| Article | Year |
|---|---|
Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Cardiovascular Diseases; Cross-Sectional | 2001 |